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Abstract 
Isolated from a wide range of sources, the genus Paenibacillus comprises bacterial species relevant to humans, 
animals, plants, and the environment. Many Paenibacillus species can promote crop growth directly via biological 
nitrogen fixation, phosphate solubilization, production of the phytohormone indole‑3‑acetic acid (IAA), and release 
of siderophores that enable iron acquisition. They can also offer protection against insect herbivores and phy‑
topathogens, including bacteria, fungi, nematodes, and viruses. This is accomplished by the production of a variety of 
antimicrobials and insecticides, and by triggering a hypersensitive defensive response of the plant, known as induced 
systemic resistance (ISR). Paenibacillus‑derived antimicrobials also have applications in medicine, including polymyx‑
ins and fusaricidins, which are nonribosomal lipopeptides first isolated from strains of Paenibacillus polymyxa. Other 
useful molecules include exo‑polysaccharides (EPS) and enzymes such as amylases, cellulases, hemicellulases, lipases, 
pectinases, oxygenases, dehydrogenases, lignin‑modifying enzymes, and mutanases, which may have applications 
for detergents, food and feed, textiles, paper, biofuel, and healthcare. On the negative side, Paenibacillus larvae is the 
causative agent of American Foulbrood, a lethal disease of honeybees, while a variety of species are opportunistic 
infectors of humans, and others cause spoilage of pasteurized dairy products. This broad review summarizes the 
major positive and negative impacts of Paenibacillus: its realised and prospective contributions to agriculture, medi‑
cine, process manufacturing, and bioremediation, as well as its impacts due to pathogenicity and food spoilage. This 
review also includes detailed information in Additional files 1, 2, 3 for major known Paenibacillus species with their 
locations of isolation, genome sequencing projects, patents, and industrially significant compounds and enzymes. 
Paenibacillus will, over time, play increasingly important roles in sustainable agriculture and industrial biotechnology.
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Introduction to Paenibacillus
Bacteria belonging to the genus Paenibacillus have been 
isolated from a variety of environments, with many of 
the species being relevant to humans, animals, plants, 
and the environment. The majority of them are found in 
soil, often associated with plants roots: these rhizobac-
teria promote plant growth and can be exploited for use 
in agriculture. Many species of Paenibacillus produce 
antimicrobial compounds that are useful in medicine or 
as pesticides, and many yield enzymes that could be uti-
lized for bioremediation or to produce valuable chemi-
cals. Some species are pathogens to honeybees or other 
invertebrates; while others are occasional opportun-
istic infectors of humans. In fact, many of these perti-
nent characteristics overlap within the same species. In 
accordance with their diverse characteristics, members of 
Paenibacillus have been discovered in disparate habitats, 
from polar regions to the tropics, and from aquatic envi-
ronments to the driest of deserts (Additional file 1).
Species of Paenibacillus were originally included in the 
genus Bacillus, which historically was defined based on 
morphological characteristics in common with the type 
species Bacillus subtilis, isolated in 1872. Any bacterium 
was classified as Bacillus if it was rod-shaped, aerobic 
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or facultatively anaerobic, and could form endospores 
allowing it to remain dormant in inhospitable condi-
tions. However, these characteristics are actually very 
ancient and not suitable for grouping species into a sin-
gle genus [1]. A study in 1988 using numerical taxonomy 
based on 188 unit characters suggested a framework for 
splitting Bacillus into several genera [2]. A more accu-
rate representation of phylogenetic relationships among 
these bacteria was attained in 1991, when 16S rRNA gene 
sequences were determined for standard strains of 51 
species then defined as Bacillus [2, 3]. Phylogenetic anal-
yses showed that these sequences segregated into at least 
five distinct clusters, one of which was reassigned to the 
novel genus Paenibacillus in 1993 [4] and includes the 
type species Paenibacillus polymyxa [5]. The name Pae-
nibacillus is derived from the Latin adverb paene, mean-
ing almost; almost a Bacillus [4].
Not long after the creation of the genus, organisms 
previously thought of as separate Paenibacillus species 
were re-classified as equaivalent: for example, Paeni-
bacillus gordonae was determined to be a synonym of 
Paenibacillus validus, and Paenibacillus pulvifaciens 
was determined to be a subspecies and later a syno-
nym for Paenibacillus larvae [6, 7]. Several species were 
also reclassified into the genus Paenibacillus, including 
Clostridium durum, Bacillus alginolyticus, Bacillus chon-
droitinus, Bacillus curdlanolyticus, Bacillus glucanolyti-
cus, Bacillus kobensis, and Bacillus thiaminolyticus [8, 9]. 
In 1997, a proposed emendation described Paenibacillus 
as having 16S rDNA sequences with more than 89.6% 
similarity, being motile by means of peritrichous flagella 
(projecting in all directions), and being non-pigmented 
on nutrient agar, among other characteristics. Species of 
this genus can be gram positive, gram negative, or gram 
variable, in addition to sharing the basal characteristics 
ascribed to Bacillus [8].
The number of useful or otherwise relevant Paeniba-
cillus species has spawned genome sequencing of 212 
strains representing 82 species, as well as 79 uncharac-
terized strains (Additional file  2), and a variety of pat-
ents (Table  1). Genome size ranges from 3.02 Mbp (for 
P. darwinianus Br, isolated from Antarctic soil [10]) to 
8.82 Mbp (for P. mucilaginosus K02, implicated in silicate 
mineral weathering [11]) and genes number from 3064 
(P. darwinianus Br) to 8478 (P. sophorae S27, a rhizo-
bacterium). Like P. darwinianus, the insect pathogens P. 
larvae and P. popilliae have genomes on the smaller side 
(4.51 and 3.83 Mbp, respectively), perhaps reflecting their 
niche specialization. The DNA G + C content of Paeni-
bacillus ranges from 39 to 59 mol% [12].
Currently, Paenibacillus is one of eight genera included 
in the family Paenibacillaceae. However, a phylogram of 
the family suggests that Paenibacillus is paraphyletic, 
with the other genera (Aneurinibacillus, Brevibacillus, 
Cohnella, Fontibacillus, Oxalophagus, Saccharibacil-
lus, and Thermobacillus) forming subsidiary clades. The 
genus Paenibacillus is therefore expected to undergo 
significant taxonomic subdivision in the future [1]. Con-
versely, the number of novel species being identified as 
Paenibacillus, and established species being reclassified 
as such, continues to grow, and the genus currently com-
prises around 200 species (Additional file 1). Despite this 
complexity, the present review attempts to summarize 
all members currently classified as Paenibacillus with 
respect to the characteristics—both positive and nega-
tive—that are most relevant to humankind.
Plant growth promotion
The genus Paenibacillus contains many species which are 
known to promote the growth of plants including maize 
[13], Populus [14], pumpkin [15], rice [16], switchgrass 
[17], and many others. Like other plant growth-promot-
ing bacteria, they accomplish this through various fac-
ets. Plant-associated species of Paenibacillus can directly 
influence plant growth by producing indole-3-acetic acid 
(IAA) and other auxin phytohormones, solubilizing inac-
cessible phosphorous into form that can be taken up by 
plant roots, and some species can also fix atmospheric 
nitrogen [18]. In addition, Paenibacillus helps to control 
phytopathogens by triggering induced systemic resist-
ance (ISR) and/or producing a variety of biocidal sub-
stances (see “Biocontrol” and “Antimicrobial peptides” 
sections).
While some plant growth promoting bacteria, includ-
ing P. macerans, are used in commercial biofertilizers, 
their use is currently limited. The establishment and 
performance of these microorganisms in the field can be 
affected by numerous environmental variables, such as 
soil pH, salinity, moisture content, and temperature [19]. 
Despite these limitations, continuing research may ena-
ble more widespread use of these biofertilizers. One ben-
efit of inoculating fields with endospore-forming bacteria 
such as Paenibacillus is their capacity to survive for long 
periods in the soil under adverse environmental condi-
tions [20].
Nitrogen fixation
Atmospheric nitrogen (N2) is relatively inert, and must 
be fixed to a usable chemical form before being incorpo-
rated into amino acids, nucleotides, and other metabo-
lites. As eukaryotes do not have the ability to fix their 
own nitrogen, its bioavailability in the soil is a major lim-
iting factor for plant growth, and farmers routinely apply 
nitrogen fertilizers to ensure crop productivity. Com-
mercial nitrogen fertilizers are produced by the Haber-
Bosch process through reducing nitrogen gas, which 
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uses fossil fuels for the energy needed, and the resulting 
carbon dioxide emissions and pollution contributing to 
global warming and adverse effects on human health. 
Additionally, over 50% of synthetic nitrogen fertilizer is 
not taken up by crops, and is instead lost to the environ-
ment where it contributes to eutrophication, greenhouse 
gas production, and acid rain [21]. Such nitrogen pollu-
tion is considered to be the second most important driver 
of anthropogenically induced global change, next to the 
perturbation of the carbon cycle [22]. However, its effects 
can be lessened by inoculating fields or crops with micro-
organisms, including some strains of Paenibacillus, that 
fix nitrogen in or around plant roots, where it is actually 
needed.
Nitrogen-fixing (diazotrophic) bacteria and archaea 
primarily use a molybdenum (Mo)-dependent nitroge-
nase (Nif ) to catalyze the reduction of N2 to bioavailable 
NH3. Synthesis of this enzyme requires a minimum of 
three structural genes and three genes for FeMo-cofactor 
biosynthesis [23]. However, optimum activity requires 
the presence of additional genes, as the specific activity 
of a nitrogenase expressed in Escherichia coli was only 
about 10% of that observed in the Paenibacillus species 
from which it was derived; and improvements were made 
with additional transgenes [24]. Alternatives to Nif have 
active site cofactors that lack Mo, instead containing both 
vanadium and iron (Vnf), or iron only (Anf) [23].
More than 20 Paenibacillus species can fix nitrogen 
[25], with single species comprising both diazotrophic 
and non-diazotrophic strains [26, 27]. The nif gene cluster 
is highly conserved among nitrogen-fixing Paenibacillus, 
with most clusters containing 9 genes within 10.5–12 kb, 
and exhibiting over 80% identity [25]. Most of the Nifs 
appear monophyletic, having likely been derived from 
a single horizontal gene transfer, followed by duplica-
tions and gene cluster loss in some lineages [27, 28]. At 
least two strains, P. riograndensis SBR5T and P. durus 
DSMZ1735, have additional nifs from a potentially inde-
pendent, more recent horizontal transfer, although these 
genes may not be functional [28]. The alternative nitoge-
nase Vnf is encoded in the genomes of P. zanthoxyli JH29 
and P. azotofixans ATCC 35681, while Anf is encoded by 
P. sophorae S27, P. forsythia T98 [25], and P. riogranden-
sis SBR5T; all of which also contain the nif cluster. Having 
Vnf or Anf, in addition to Nif, may provide an selective 
advantage in certain circumstances, as anf shows higher 
expression under molybdenum-depleted conditions [28].
The ability of organisms to fix nitrogen can be identi-
fied by growth on nitrogen-free medium, while reliable 
estimates of nitrogenase activity can be obtained using 
15N2 fixing assays. However, acetylene reduction assays 
are less costly than 15N2 and are sufficient to estimate 
relative nitrogenase activities. These assays are based on 
the ability of nitrogenases to also reduce acetylene (C2H2) 
to ethylene (C2H4). Such assays have found a wide range 
of relative activities among nitrogen-fixing Paenibacillus 
species, for example, with P. zanthoxyli DSM 18202 pro-
ducing 140 times more activity than P. peoriae DSM 8320 
[29].
Phosphate solubilization
Next to nitrogen, phosphorus is the second most impor-
tant element limiting plant growth and productiv-
ity. Although it is abundant in soils, only 0.1% exists in 
a soluble form that can be taken up by plant roots; the 
remainder forms insoluble mineral complexes, or is 
immobilized in organic matter. Chemical phosphorus 
fertilizers are therefore used to supplement soluble phos-
phorus on most agricultural soils, but these are costly 
and adversely impact the environment [19].
Unlike nitrogen, phosphorus fertilizer is a finite 
resource obtained from rock phosphate, and once high-
quality deposits are used, the shift to lower grade rock 
will result in even higher costs. The manufacturing pro-
cess emits poisonous hydrogen fluoride gas. Once applied 
to the field, less than 30% of the chemical fertilizer is typi-
cally used by the plant, with much of the rest incorpo-
rating into inorganic mineral complexes within the soil. 
The rise in insoluble phosphorus can disturb microbial 
diversity, eventually leading to reduced soil fertility; and 
trace amounts of heavy metal impurities in the fertilizer 
can accumulate over time. Eutrophication can also result 
as phosphorus-rich soil erodes into aquatic systems [19].
As is the case for nitrogen, the application of chemi-
cal phosphorus fertilizer could be reduced by inoculat-
ing fields with phosphorus-solubilizing microorganisms, 
such as Paenibacillus. While bacteria may have draw-
backs when compared to phosphorus solubilizing fungi, 
such as lower activity and a tendency to lose activity 
after repeated sub-culturing [19], some may nonetheless 
become preferred bio fertilizers due to additional quali-
ties that simultaneously benefit plant growth.
Phosphorus solubilizing microorganisms use a variety 
of mechanisms that make phosphorus available to plants, 
with the principal method being organic acid (especially 
gluconic acid) production. Such acids can directly dis-
solve mineral phosphorus through anion exchange, che-
late metal ions, or lower soil pH to release phosphorus 
from the mineral complex. Microorganisms also release 
phosphorus from their substrates during enzymatic deg-
radation, and from their own cells upon death [19].
Genomic analyses suggest that most Paenibacil-
lus strains can solubilize phosphorus through glu-
conic acid production: a study of 35 strains comprising 
at least 18 species found that all but two strains have 
genes involved in gluconic acid production, encoding 
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glucose-1-dehydrogenase and gluconic acid dehydro-
genase. The strains apparently lacking these genes were 
P. beijingensis 1–18 and P. terrae HPL-003; while those 
having the genes included strains from P. azotofixans, 
P. curdlanolyticus, P. dendritiformis, P. elgii, P. forsythia, 
P. graminis, P. lactis, P. massiliensis, P. mucilaginosus, P. 
peoriae, P. polymyxa, P. sabinae, P. sonchi, P. sophorae, 
P. vortex, and P. zanthoxyli [27]. Genes for the uptake 
and degradation of phosphonates, which containing the 
highly stable C-P bond, and for a phosphate-specific 
transport system, were found in all analysed genomes 
[27]. Phosphorus solubilisation has been confirmed by P. 
elgii [30], P. kribbensis [31], P. macerans [32], P. mucilagi-
nosus [33], P. polymyxa [32], P. xylanilyticus [34], and sev-
eral unclassified strains.
Iron acquisition
Like phosphorus, iron is abundant in soil in mainly in 
non-bioavailable form. Particularly in alkaline or chalky 
soils, it forms largely insoluble Fe3+ oxy-hydroxides, 
which are not readily used by either microorganisms or 
plants. Most microorganisms therefore reduce Fe3+ to 
Fe2+ using ferrireductases or solubilize it with extracel-
lular, low molecular weight Fe3+ chelators called sidero-
phores [35], which are released under iron limited 
conditions. The soluble Fe3+-siderophore complexes are 
available to plants as well as microorganisms [36], being 
recognized by specific membrane receptors and trans-
ported into cells [37].
Siderophores are synthesized mainly by nonribosomal 
peptide synthetases (NRPSs), which are encoded by gene 
clusters. These multienzyme complexes consist of vari-
ous modules that each incorporate one or more specific 
amino acids into a peptide backbone (see also “Nonribo-
somal lipopeptides” section). The three types of sidero-
phores are classified based on their functional groups, 
being catecholates, hydroxamates, and α-hydroxy car-
bolates [38]. However, few siderophores have thus far 
been characterized from Paenibacillus.
Paenibacillus larvae produces a catecholate -type 
siderophore called bacillibactin, which is also made by 
Bacillus subtilis and members of the Bacillus cereus sensu 
lato group [38]. Bacillibactin is a cyclic trimeric lactone of 
2,3-dihydroxybenzoate (DHB)-glycine-threonine. Similar 
to bacillibactin, paenibactin is a cyclic trimeric lactone 
of 2,3-DHB-alanine-threonine produced by P. elgii B69, 
the difference being the amino acid inserted between 
the DHB and threonine units [37]. Catecholates have not 
been detected in cultures of P. polymyxa SQR-21, which 
instead produces hydroxamate-type siderophores at low 
concentrations in the late log phase [35]. Siderophore 
synthesis gene clusters are present only in some strains of 
some Paenibacillus species, and are thought to have been 
obtained from fairly recent events of horizontal gene 
transfer [26, 37].
Aside from siderophore production, Paenibacillus may 
promote iron uptake by plants via other mechanisms. 
P. polymyxa BFKC01 transcriptionally activates plant 
genes involved in iron deficiency responses, including the 
membrane bound ferric chelate reductase fro2 and the 
divalent metal transporter irt1, as well as genes involved 
in the synthesis of iron-mobilizing phenolic compounds 
[39]. Paenibacillus-produced organic acids, such as oxalic 
acid, could also conceivably contribute to iron uptake, 
but release of such acids does not appear to be iron regu-
lated [35].
Phytohormone production
Auxins are hormones that are crucial regulators of gene 
expression and development throughout a plant’s life, 
participating in cell division, elongation, fruit develop-
ment and senescence. There are multiple classes of aux-
ins, but the first identified and most abundant in nature is 
indole-3-acetic acid (IAA) [40]. Although plants are able 
to produce their own phytohormones, they can also uti-
lize foreign sources produced by other organisms.
In addition to plants, IAA is synthesized by fungi and 
bacteria, including Paenibacillus and most other plant-
associated bacteria [20]. The production of IAA by 
Paenibacillus is thought to contribute to plant growth 
promotion [41]. However, this hormone has a complex 
relationship with plants, being produced by both plant-
growth-promoting and phytopathogenic bacteria. Lower 
levels of exogenous IAA typically increase plant growth 
and productivity, while high levels lead to disease sus-
ceptibility [20]. Perhaps auspiciously, the tryptophan 
precursor of IAA is energetically costly, and considerable 
amounts are only made with an excess of tryptophan, 
which may be exuded from the plant, typically during the 
stationary phase of bacterial growth [41].
Three different enzymatic pathways have been identi-
fied that convert tryptophan to IAA; in bacteria, the most 
common is the indole-3-pyruvic acid pathway, which is 
also present in plants. In this pathway, an aminotrans-
ferase deaminates tryptophan to yield indole-3-pyruvic 
acid, which is then converted to indole-3-acetaldehyde 
by a decarboxylase in the rate-limiting step. Finally, 
indole-3-acetaldehyde is oxidized to IAA via an unknown 
enzyme [20, 41].
Genes encoding putative indolepyruvate decarboxylase 
(IpdC), a key enzyme in the indole-3-pyruvic acid path-
way, are present in all analyzed Paenibacillus genomes, 
with over 96% amino acid identity between strains across 
98% of the sequence [27]. IpdC belongs to a family of 
enzymes that exhibit some level of substrate promis-
cuity, and substitution of only a few amino acids in the 
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active site can shift the primary affinity to another sub-
strate. The active site must therefore be analysed in detail 
to confirm a gene’s identity as an ipdC homologue whose 
primary function is IAA synthesis [41]. However, the 
Paenibacillus genomic analysis did not identify genes 
involved in the other IAA pathways, that is, tryptophan 
monooxygenase or indole-3-acetamide hydrolase, sug-
gesting that this genus most likely relies on the indole-
3-pyruvic acid pathway [27].
Biocontrol
Perhaps the most notable plant-growth promoting fea-
ture of Paenibacillus species comes from their numer-
ous biocontrol capabilities. By inducing the plant’s own 
resistance mechanisms or by producing biocidal sub-
stances, Paenibacillus can neutralize a diverse variety of 
phytopathogens and insect herbivores. P. polymyxa alone 
has been shown to provide protection to cauliflower [42], 
pea [43], ginseng [44], cucumber [45], chickpea [46], 
peanut [47], soybean [48], pepper [49], and more. Other 
species of Paenibacillus that have biocontrol properties 
include P. alvei [50], P. brasilensis [51], P. dendritiformis 
[52], P. ehimensis [53], P. elgii [54], P. kobensis [55], P. len-
timorbus [56], P. macerans [57], P. peoriae [58], and P. 
thiaminolyticus [59].
Tolerance of some Paenibacillus species to commercial 
fungicides and insecticides [60] indicates the possibility 
of using these microorganisms in combination with exist-
ing control solutions. However, when considering Paeni-
bacillus or its compounds for biocontrol, it is important 
to note that competition can occur both ways. For exam-
ple, while low levels of fusaric acid, a toxin produced by 
the fungus Fusarium oxysporum, increase production of 
the antifungal enzyme β-1,3-glucanase by P. polymyxa 
strains WR-2 and SQR-21, higher levels of fusaric acid 
actually decrease their production and result in reduced 
P. polymyxa growth [61]. Furthermore, Paenibacillus may 
compete with other beneficial organisms [62, 63].
Induced systemic resistance
Many beneficial rhizobacteria and root-associated mutu-
alists, including members of Paenibacillus, can trigger 
induced systemic resistance (ISR) when present in high 
enough population densities. ISR is a latent defense 
mechanism occurring in plant tissues that are spatially 
separated from the inducer, providing enhanced protec-
tion against a range of pathogens or pests. Rather than 
immediately activating a defensive state, ISR primes for 
faster and stronger defenses by hypersensitizing the plant 
to potential threats [64]. A variety of Paenibacillus spe-
cies seem to elicit ISR against pathogenic bacteria [49, 
65], fungi [50, 66–68], nematodes [69], and viruses [70].
The ISR pathway begins when the plant recognizes 
elicitors from the beneficial microorganism, such as 
structural proteins, enzymes, reactive oxygen species, 
or volatile organic compounds [64, 71]. ISR can lead to 
increased systemic levels of the plant hormone salicyclic 
acid (SA-dependent response), or to an SA-independent 
response. The latter can include increased transcrip-
tion of genes that are regulated by the plant hormones 
jasmonic acid, or enhanced expression of genes that are 
responsive to jasmonic acid or ethylene, which are then 
induced upon attack. In addition, SA-independent ISR 
can prime for physical responses such as enhanced cal-
lose deposition at sites of pathogen entry, which is reg-
ulated by abscisic acid and creates a structural barrier 
against further attack. While there are exceptions, SA-
dependent ISR typically induces mechanisms against 
biotrophic pathogens (those requiring that the host cells 
remain alive), while the jasmonic acid/ethylene pathway 
protects against cell death-provoking necrotrophs and 
against insect herbiviores [64].
Among Paenibacillus species, ISR has been demon-
strated for P. polymyxa, P. alvei, P. elgii, and P. lentimor-
bus. For example, P. polymyxa strain KNUC265 was 
shown to protect against the bacterial pathogens Xan-
thomonas axonopodis and Erwinia carotovora in pep-
per and tobacco, respectively, using bacterial volatiles 
and diffusible metabolites as elicitors [49]. P. polymyxa 
E681 was shown to use volatile organic compound elici-
tors to protect Arabidopsis thaliana against the bacte-
rium Pseudomonas syringae via primed transcription of 
salicylic acid, jasmonic acid, and ethylene signaling genes 
[65]. Consistent with the typical roles of SA-dependent 
and jasmonic acid/ethylene pathways, Pseudomonas 
syringae is described as a hemibiotrophic pathogen, with 
both biotrophic and necrotrophic stages [72]. Similarly, 
Arabidopsis thaliana is primed by P. alvei K165 against 
a hemibiotrophic fungus [54], Verticillium dahlia, by 
both salicylate and jasmonate-dependent pathways [68]; 
while cucumber is primed by P. elgii MM-B22 against 
the hemibiotrohic fungus [54] Colletotrichum orbicu-
lare, responding to attack with defense-related enzymes 
and H2O2-induced cell death [67]. Priming of tobacco 
by P. lentimorbus B-30488 also results in accumulation 
of defense-related enzymes in response to cucumber 
mosaic virus infection [70].
Insecticides
Paenibacillus species have been shown to kill larvae of 
pest insects including beetles [73] and lepidopterans [74]. 
Paenibacillus popilliae, which infects larvae of the Japa-
nese beetle, Popillia japonica, was the first microbial con-
trol agent registered in the US for use against an insect. 
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However, its use was never widespread due in part to the 
inability of this particular species to be cultured in syn-
thetic media [75]. Nonetheless, research continues into 
the potential of Paenibacillus species for insect pest con-
trol, with the effective proteins including chitinase and 
crystal protein (Cry).
Chitinase enzymes produced by Paenibacillus hydro-
lyse chitin, which is a structural polysaccharide of insect 
exoskeletons and gut linings, leading to low feeding rates 
and death of infected insects. Both Paenibacillus sp. D1, 
from a seafood industry effluent treatment plant, and its 
isolated chitinase have been shown to cause concentra-
tion-dependent mortality of cotton bollworm (Helicov-
erpa armigera) when coated onto leaves fed to the larvae 
[76]. Paenibacillus sp. D1 and its chitinase are tolerant to 
common insecticidal chemicals, and the chitinase itself 
is also highly stable in the field at 40  °C [60], indicating 
the potential of the organism or its enzyme to be used as 
insecticide in the field.
Cry proteins are best known for conferring insecti-
cidal activity to the bacterium Bacillus thuringiensis and 
to genetically modified crops. Following ingestion, these 
proteins form pores in the insect midgut epithelial cells, 
resulting in cell lysis and death [77]. Cry homologs from 
Paenibacillus lentimorbus strain Semadara, which was 
isolated from larvae of the beetle Blitopertha orientalis, 
have been shown to cause mortality of beetle larvae [78]. 
Genes encoding Cry have also been found in P. popil-
liae [79] and Paenibacillus spp. Kh3 [80]. In addition, P. 
polymyxa NMO10 has been genetically engineered with 
Cry1C from B. thuringiensis in order to combine the 
insecticidal activity of Cry and the growth promotion 
properties of P. polymyxa. The modified strain demon-
strated greater toxicity than B. thuringiensis against lepi-
dopteran insects [81, 82].
While insecticidal activities of Paenibacillus species 
may contribute to insect pest control, it is important to 
note that interactions between species in the field can 
be complex and non-target effects of biocontrol agents 
needs to be considered. For example, large populations of 
Paenibacillus species, or P. polymyxa alone, near the root 
system can actually increase the susceptibility of plants to 
aphids, possibly via increased levels of the plant growth 
promoting hormone IAA [83]. Furthermore, while vari-
ous Paenibacillus species suppress parasitic nematodes, 
most notably the root-knot nematode Meloidogyne incog-
nita, P. nematophilus has been found to impede dispersal 
of the beneficial nematode Heterorhabditis megidis and 
reduce its infectivity of moth larvae [63].
Antimicrobials
Many Paenibacillus species compete with other micro-
organisms through the production of a wide range of 
antimicrobial compounds. In one study, 25 of 55 isolates 
from water and soil exhibited a broad inhibition spec-
trum against tested bacteria and pathogenic fungi Lor-
entz RH, Ártico S, Da Silveira AB, Einsfeld A and Corção 
G [84], suggesting that a good proportion of Paenibacil-
lus species are likely to produce antimicrobials. Yet diver-
sity exists even within the same species: of 25 strains of 
P. polymyxa, 15 were strongly inhibitory to the oomycete 
pathogen Phytophthora capsici, while 10 showed weak 
or no antimicrobial effect [85]; and genome sequencing 
confirms the diversity of antimicrobial-encoding gene 
clusters among P. polymyxa strains [26, 27].
Various Paenibacillus strains, or their isolated antimi-
crobial compounds, could therefore be useful in control-
ling phytopathogenic microorganisms, leading to lower 
usage of chemical biocides which can have negative 
environmental effects. Soilborne fungal pathogens, in 
particular, require high doses of chemical fungicides for 
control due to their wide host spectra and persistence in 
soil [53]. The antimicrobial activities of Paenibacillus may 
also be useful for post-harvest control of food-borne bac-
teria, such as Salmonella, that are pathogenic to humans 
[86].
The antimicrobials produced by Paenibacillus include 
peptides, enzymes, and volatile organic compounds 
(VOCs). While antimicrobial peptides are extremely sig-
nificant for biocontrol in agriculture, the purified or syn-
thesized peptides also have realised and potential uses 
in medicine and food processing, and are therefore dis-
cussed further in a separate section (see “Antimicrobial 
peptides” section).
Hydrolytic enzymes of Paenibacillus can attack the cell 
walls of fungal and oomycete competitors. Cell walls of 
filamentous fungi contain a large fraction of β-1,3-glucan 
and chitin, while those of oomycetes consist primarily of 
β-1,3-glucan, β-1,6-glucan and cellulose; and both con-
tain up to 11% protein. Various species of soil-dwelling 
Paenibacillus have been found to produce glucanses, 
chitinases, cellulases, and proteases that are implicated 
in the destruction of eukaryote cell walls. For example, 
crude enzyme extract from P. ehimensis KWN38 was 
shown to deform hyphal morphology and prevent growth 
of the basidiomycete fungus Rhizoctonia solani, the asco-
mycete fungus Fusarium oxysporum, and the oomycete 
Phytophthora capsici, all of which are phytopathogens 
[53]. Glucanases and chitinases from strains including P. 
ehimensis IB-X, P. ehimensis MA2012, and P. polymyxa 
A21 have been shown to damage cell wall structures and/
or inhibit R. solani, the oomycete Pythium aphaniderma-
tum, and the ascomycetes Alternaria alternata, Botrytis 
cinerea, Colletotrichum gloeosporioides, and Drechlera 
sorokiniana [87–90]. A chitinase from Paenibacillus sp. 
D1 also exhibited high stability in presence of commonly 
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used fungicides, suggesting the potential of some hydro-
lytic enzymes as additives to chemical fungicides [91].
VOCs can enhance interactions between soil-dwelling 
microorganisms, as these compounds diffuse through 
air-filled pores in the soil to reach physically separated 
organisms [92]. A large number of VOCs are produced 
by Paenibacillus species [93, 94] as well as other microor-
ganisms [92]. For example, P. polymyxa WR-2 was found 
to produce 42 VOCs, over 30 of which had some degree 
of antifungal activity against F. oxysporum, including 13 
that completely inhibited its growth. The compounds 
included benzenes, aldehydes, keytones, and alcohols, 
although some were produced in low quantities; with 
benzothiazole, benzaldehyde, undecanal, dodecanal, 
hexadecanal, 2-tridecanone and phenol being the main 
antifungal compounds [94]. Antimicrobial VOCs have 
application for biocontrol of agricultural pathogens, 
post-harvest diseases (particularly of fruit), and building 
molds [92].
In addition to the antimicrobials described above, a 
non-volatile organic compound, methyl 2,3-dihydroxy-
benzoate, from P. elgii HOA73 was found inhibited 
growth of B. cinerea, F. oxysporum. P. capsici, and R. 
solani [95].
Antimicrobial peptides
Further to “Antimicrobials” section, Paenibacillus pro-
duces antimicrobial peptides with realised or potential 
applications in agriculture, medicine, and food process-
ing. These peptides are of two types: ribosomally-syn-
thesized bacteriocins, and non-ribosomally synthesized 
peptides, where amino acids are incorporated indepen-
dently of messenger RNA.
Bacteriocins
Bacteriocins are ribosomally synthesized, proteinaceous 
toxins that inhibit the growth of bacteria that are related 
to the producer. Paenibacillus species are known to pro-
duce at least two of the three classes of bacteriocins, 
being lantibiotics and pediocins.
Lantibiotics, also known as Class I bacteriocins, con-
tain the non-coded amino acid lanthionine [96]. They 
are typically active against Gram-positive bacteria, as 
the outer membrane of Gram-negative bacteria presents 
a natural barrier. However, some gram negatives can be 
affected at high concentrations [97].
Lantibiotics are usually expressed at the late exponen-
tial phase or early stationary phase of bacterial growth, 
and are encoded in a cluster along with genes required for 
their extensive post-translational modifications [96]. In P. 
polymyxa OSY-DF, for example, the paenibacillin prepro-
peptide is encoded in a cluster that also contains puta-
tive genes for lantibiotic dehydratase, lantibiotic cyclase, 
acetylase, peptidase, and an ATP-binding cassette (ABC) 
transporter that may function for export to the extracel-
lular space [96]. Other lantibiotics include paenicidin A 
produced by P. polymyxa NRRL B-30509 [98] and penisin 
produced by Paenibacillus sp. strain A3 [99].
Lantibiotics in Paenibacillus are fairly recent discov-
eries, with Paenibacillin first reported in 2007 [100]. 
However, the lantibiotic Nisin, produced by Lactococcus 
lactis, has been in commercial use since the 1950s, both 
as a food preservative and in veterinary medicine. Lanti-
biotics have low toxicity toward mammals and are poorly 
immunogenic, meaning there is little risk of adverse 
effects [97]. Paenibacillin has the advantages of pH and 
heat stability, as well as activity against a broad range of 
foodborne pathogens and spoilage bacteria, making it an 
attractive candidate for food preservation [101].
Compared to these lantibiotics, less research has been 
done on Paenibacillus-produced pediocins, also known 
as Class II bacteriocins. Pediocins are nonmodified, lin-
ear peptides, and include SRCAM 37 and SRCAM602 
produced by P. polymyxa [101].
Nonribosomal lipopeptides
In contrast to bacteriocins, many antimicrobial pep-
tides produced by Paenibacillus are synthesized nonri-
bosomally, independently of RNA. Here, the amino acid 
residues are pieced together by nonribosomal peptide 
synthetases (NRPSs), which are multienzyme complexes 
that can incorporate a mixture of d and l amino acids. 
Each module of an NRSP incorporates one or more spe-
cific amino acids into the peptide chain. Resulting pep-
tides show great diversity in sequence and structure, and 
an enhanced resistance to proteolytic enzymes. The non-
ribosomal lipopeptides act primarily by disrupting mem-
branes of the target cells, and because it is difficult for 
target organism to reorganize their membranes, develop-
ment of resistance is usually slow [102].
Nonribosomal lipopeptides can be categorized as linear 
cationic, cyclic cationic, or cyclic noncationic. Although 
they are the most amenable to chemical synthesis, lim-
ited research has been conducted on linear cationic non-
ribosomal lipopeptides. In Paenibacillus, these include 
saltavalin, jolipeptin, and tridecaptins [102].
Cyclic cationic lipopeptides
The most thoroughly researched cyclic cationic lipopep-
tides from Paenibacillus are the polymyxins, first iso-
lated from P. polymyxa in 1947, although they are also 
produced by strains of P. alvei [103], P. kobensis [55], and 
possibly other species. These are a family of peptides 
each consisting of a polycationic diaminobutyryl-con-
taining heptapeptide ring and tripeptide side chain with 
a fatty acid derivative at the N-terminus [104]. Members 
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of the family include polymyxin A, B, C, D, E (also called 
colistin), M (also called mattacin), P, S, and T [103–106]. 
These polymyxins differ from each other in amino acid 
composition at residues 3, 6, and 7, including D vs L ste-
reochemistry of amino acids. Subgroups (e.g. polymyxin 
E1 and E2) differ in the lipid moiety and/or the amino 
acid at residue 7 [103]. Amino acid diversity is thought 
to arise from combinatorial chemistry, due to mixing and 
matching of alleles of the NRPS modular domains [104]. 
Polymyxin gene clusters found to date each encode three 
multi-modular NRPSs and two ABC transporters [103, 
107].
Polymyxins bind to the lipid A component of lipopoly-
saccharide on the outer membrane of gram-negative bac-
teria to disrupt the outer membrane, then permeabilize 
and disrupt the inner membrane. Most cases of resist-
ance occur in strains that have modified lipid A to reduce 
its net negative charge, thereby reducing affinity for poly-
myxin [102].
Polymyxins B and E are produced industrially from 
P. polymyxa strains [103]. They are used in ointments, 
such as the antibiotic creams Neosporin and Polysporin 
(both contain polymyxin B), for the treatment and pre-
vention of topical skin infections; and as last-resort treat-
ments for multidrug resistant internal infections [108]. 
While polymyxins were used extensively from the 1940s 
until the 1970s to treat gram-negative bacterial infec-
tions, their clinical uses are currently limited primarily 
because of toxicity to the human central nervous system 
and kidneys. While this toxicity may be less severe than 
previously reported [102], synthetic production with 
modifications can create new polymyxins with improved 
pharmacokinetic properties as well as activity against 
resistant bacteria [109].
Other cyclic cationic lipopeptides produced by Pae-
nibacillus include octapeptins (e.g. battacin), paeni-
bacterin, polypeptins (e.g. pelgipeptin), and gavaserin. 
Octapeptins have the structure of truncated polymyxins, 
but are active against both Gram-negative and Gram-
positive bacteria, and are less toxic [102]. Paenibacterin is 
a cyclic 13-residue amino acid produced by P. thiamino-
lyticus OSY-SE, with activity against Gram negative and 
positive bacteria [59].
Cyclic noncationic lipopeptides
The cyclic noncationic lipopeptides found so far in Pae-
nibacillus are fusaricidins, first reported in P. polymyxa 
KT-8 in 1996 [110]. These are hexapeptide rings that con-
tain one or more ester bonds in addition to the amide 
bonds (depsipeptides), with an attached guanidinylated 
ß-hydroxy fatty acid [104, 111]. A single operon produces 
a variety of fusaricidins, differing in their incorporation 
of amino acids at three of the six positions in the peptide 
ring. The diversity here is due to relaxed substrate speci-
ficity of the NRPS [112], in contrast to the modular 
mixing of polymyxin synthases. Fusaricidins are active 
against fungi, including many important phytopathogens, 
and a variety of gram-positive bacteria. Both naturally 
occurring structures and synthetic modifications can be 
chemically synthesized, creating improved stability and 
decreased nonspecific cytotoxicity toward human cells 
[111].
Other medical applications
In addition to a diverse array of antimicrobials, Paeni-
bacillus produce other compounds that may be useful 
in medicine and dentistry. Their exo-polysaccharides 
(EPS) have antioxidant and anti-tumour properties, while 
mutanase enzymes may help to reduce tooth decay.
Microbial EPSs are water-soluble polymers that attach 
to the cell surfaces or are released into the medium. 
Strains of Paenibacillus produce EPSs with varying char-
acteristics that may be medically useful. For example, 
those from P. polymyxa SQR-21 and P. polymyxa EJS-3 
have superoxide scavenging activity and inhibit lipid per-
oxide [113, 114]. Some of these EPSs have been found to 
reduce oxidative stress in the livers of mice and inhibit 
in vitro growth of gastric cancer cells [114].
Mutanases, also called (1→3)-α-glucanases, from Pae-
nibacillus may be useful to help prevent tooth decay. 
These enzymes break down branched (1→3),(1→6)-α-D-
glucans (mutans) which are produced by commensal 
streptococci and which form a major component of den-
tal biofilm (plaque) that can harbor cariogenic bacteria. 
In contrast to the other polysaccharides and proteins in 
the biofilm, mutans are resistant to enzymes produced 
by oral microorganisms, and are substantially rigid and 
water-insoluble, thus are not dissolved and washed away 
by oral fluid [115].
Mutanases are produced by fungi and bacteria, includ-
ing P. curdlanolyticus, P. glycanilyticus, and P. humicus. 
However, these enzymes are not widespread in nature 
and are not produced by oral microorganisms, with pro-
ducing bacteria usually isolated from soil. The bacterial 
enzymes are typically endo-(1→3)-α-glucanases, which 
cleave internal (1→3)-α-linkages at random sites along 
the glucan chain. These mutanases tend to be more stable 
than their fungal counterparts, and are active at a higher 
pH that is more consistent with the oral environment 
[115].
A marketed oral rinse, Biotene PBF (Laclede Profes-
sional Products), contained mutanase among other 
components, but the product’s effectiveness was not 
proven, which may be due to a variety of reasons. In 
many cases, mutanase production requires inducing 
(1→3)-α-glucans, which have been difficult to make in 
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quantities large enough to support products with high 
enzyme concentrations. However, (1→3)-α-glucan com-
ponents of fungal cell walls have more recently been 
shown to induce mutanase expression in Paenibacillus 
and other organisms [115].
Process manufacturing
Paenibacillus strains produce a variety of enzymes with 
potential applications in industrial process manufac-
turing for detergents, food, textiles, paper, and biofuel; 
including amylases, cellulases, hemicellulases, lipases, 
pectinases, and lignin-modifying enzymes (Additional 
file  3). Although enzymes sourced from Paenibacillus 
are not presently used in these processes, the search is 
ongoing for enzymes that are highly active under indus-
trially-relevant conditions, have improved stability, or 
can be produced at a lower cost than currently available 
alternatives.
The laundry and dish detergents industry is the pri-
mary consumer of industrial enzymes. Proteases, lipases, 
amylases, and sometimes hemicellulases, are used to 
break down food and other organic residues, such as 
blood and grass stains. Cellulases are also used in laun-
dry detergents to restore the smooth look and feel cot-
ton-based fabric, by removing small balls of fibers that 
form on the cloth during wearing and washing. The 
other major industry to use enzymes is food, feed, and 
beverages. Here, amylases convert starches into sugar 
sweeteners such as high-fructose corn syrup, and create 
precursors for brewing alcoholic beverages. Cellulases 
and pectinases are used to extract and clarify juices, and, 
along with hemicellulases, to improve the nutritional 
quality of animal feeds. In the textile industry, pectinases, 
proteases, and lipases remove impurities from cotton and 
enhance wettability for dyeing and finishing; amylases 
remove coating agents from yard after it is woven (desiz-
ing); and cellulases can produced a “stonewashed” denim 
finish. For paper products and cellulosic biofuel, micro-
bial enzymes can help remove lignin that causes paper to 
yellow and reduces the availability of fibers for saccharifi-
cation and fermentation to biofuels. After lignin removal, 
cellulases and hemicellulases can alter fiber properties 
for paper manufacturing, or hydrolyze fibers for bioetha-
nol or biobutanol production. For an alternative biofuel, 
lipases can serve as transesterification catalysts for bio-
diesel production [116].
Cold-active enzymes are desirable for laundry deter-
gents, as washing with cold water reduces energy con-
sumption and fabric wear. Fittingly, cold-active protease, 
amylase, xylanase, and cellulase are efficiently produced 
by P. terrae [117]. For most other applications, thermo-
stability and activity under harsh conditions are desired. 
Accordingly, a cellulase from P. chitinolyticus CKS1 has 
optimal activity at 80 °C and pH 4.8 [118]; while another 
from P. tarimensis retains high activity from pH 3.0 to 
10.5, from 9 mM to 5 M NaCl, at 80 °C in high salt, and in 
the presence of organic solvents, EDTA, and heavy met-
als [119].
Bioremediation
A variety of industries including petroleum, textiles, pulp 
and paper, and other chemical industries can uninten-
tionally or intentionally release large amounts of organic 
pollutant compounds and heavy metals. Paenibacillus 
species may be utilized in the removal or degradation of 
these environmental pollutants, through bioflocculation 
or enzymatic activities.
Often used for wastewater treatment, flocculation is a 
process that removes suspended particles from liquids, 
frequently through the addition of chemicals (floccu-
lants) that promote aggregation. Many microorganism 
including bacteria, fungi, and algae can produce bio-
logical flocculants consisting of polysaccharides, pro-
teins, or other macromolecules. Strains of P. jamilae, P. 
macerans, P. polymyxa, and P. validus have been shown 
to promote bioflocculation of heavy metal ions or acid 
dyes; and P. elgii B69 produces an exopolysaccharide 
(EPS) bioflocculant that can remove multiple pollutants 
including heavy metal ions, dyes, and kaolin clay over 
a wide pH range [120]. Paenibacillus could therefore 
be used to help remove contaminants from a variety of 
wastewaters.
To degrade contaminants, either in wastewaters or 
at sites of environmental spills, Paenibacillus can pro-
duce various enzymes that metabolize aliphatic and 
aromatic organic pollutants, including oxygenases, dehy-
drogenases, and ligninolytic enzymes [121, 122]. The 
textiles industry produces multiple chemicals that can 
pollute natural waters and soils, most notably dyes that 
are released due to inadequate wastewater treatment 
[123]. Strains of Paenibacillus, either on their own or in 
concert with other bacteria, are able to degrade many tex-
tile dyes [124–126] and polyvinyl alcohol (PVA), which is 
used as a coating for textile and paper fibers [127]. Other 
hazardous effluents produced by pulp and paper mills 
can be decontaminated by Paenibacillus [128].
Paenibacillus strains can also degrade pollutants 
derived from extracting, refining, and transporting petro-
leum and coal tar, including crude oil [129], diesel fuel 
[130], bitumen [131], disulfide oils [132]; and the poly-
cyclic aromatic hydrocarbons (PAHs) naphthalene [133], 
phenanthrene [134], and pyrene [135]. Strains can also 
degrade the chemical gasoline additives ethyl tert-butyl 
ether [136] and benzene [134], the latter of which is also 
used in the production of chemicals and plastics, includ-
ing nylon.
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Pathogenicity
Some Paenibacillus species are known to infect various 
organisms, including honeybees and the parasite vec-
tor Biomphalaria glabrata, and occasionally present as 
opportunistic infections in humans.
Honeybee disease
The most studied disease associated with Paenibacillus 
is American Foulbrood (AFB), caused by P. larvae. AFB 
afflicts honeybee (Apis species) colonies globally, and is 
the most destructive brood disease [137].
Although tylosin, lincomycin, and oxytetracycline [138] 
are effective antibiotics against P. larvae, antibiotics are 
poorly metabolized by honeybees, and their residues or 
those of their metabolites can be stable in honey for over 
a year. Elimination of the residues can only occur when 
the honeybees consume all of it or when the beekeeper 
removes the contaminated food [139]. Residual antibi-
otics or their metabolites cause issues when the honey 
is meant for human consumption, as they can trigger 
allergic reactions, harm healthy microbiota, and confer 
resistance to pathogenic bacterial strains. Additionally, 
P. larvae resistance to antibiotics such as oxytetracycline 
has become increasingly more common in recent years 
[140]. The current most typical solution to deal with an 
AFB affliction is to burn the entire hive.
AFB is caused by four strains of P. larvae, named ERIC 
I-IV based on the identities of their enterobacterial repet-
itive intergenic consensus (ERIC) sequences. ERIC I and 
II are the types typically isolated from afflicted hives, as 
ERIC III and IV are less virulent [38, 140–145]. While 
ERIC II is the most virulent strain, ERIC I is more preva-
lent globally, likely because it can infect all honeybee 
subspecies, whereas ERIC II is restricted to certain sub-
species [137].
As the most virulent strain, P. larvae ERIC II has a lar-
val LT100 (time it takes the entire colony’s larvae to die) of 
just 7 days [145]. This strain produces a unique functional 
S-layer protein which facilitates attachment of the bac-
teria to the peritrophic matrix that lines the honeybee’s 
midgut epithelium [146]. By contrast, P. larvae ERIC I 
has a larval LT100 of 12 days [145] and produces a toxin 
known as the C3larvin toxin which may contribute to its 
pathogenicity. Although its target substrate has not been 
determined, this toxin acts as an ADP-ribosyltransferase 
and is lethal when expressed in yeast in vitro [147].
Both ERIC I and ERIC II have an invasive spore stage 
and a non-invasive vegetative stage. Initial ingestion of 
spore-contaminated food by the larvae marks the begin-
ning of the non-invasive phase. The spores travel to the 
midgut lumen and germinate, after which the bacteria 
proliferate rapidly. Honeybee larvae are most susceptible 
to infection within the first 36 h after hatching, and only 
a few spores are needed to initiate infection. After this 
window, the peritrophic matrix is too thick for the bacte-
ria to penetrate and colonization is never achieved. Both 
strains use chitinases to degrade the peritrophic matrix 
for both nourishment and access to the midgut epithe-
lium [146].
The S-layer protein expressed by ERIC II facilitates ini-
tial association of the bacteria to the peritrophic matrix, 
and ERIC I may have a similar protein. If the bacteria 
are successful in degrading the peritrophic matrix, they 
eventually penetrate into the midgut epithelium and the 
haemocoel using chitinases and proteases, marking the 
invasive phase. The host larvae dies soon after from bac-
teremia [145]. Adult honeybees are not susceptible to 
infection, and so in the process of cleaning contaminated 
cells they tend to transfer spores all over the hive. In this 
way the infection spreads horizontally. The infection can 
also spread vertically when a contaminated mother col-
ony infects its daughter swarm upon establishment of a 
new colony. The horizontal mode of transmission is much 
more virulent and can occur both within and between 
hives [148]. Further attributing to the pathogenicity of 
P. larvae are the paenilimicins and paenilarvins that it 
produces. Paenilimicins are antimicrobials that fight eco-
logical niche competitors and are not directly involved in 
killing the bee larvae, while paenilarvins are antifungal 
compounds which also negatively affect bee larvae [142, 
143]. As such, paenilicmins and paenilarvins promote the 
survival and colonization of P. larvae within honeybee 
larvae, while paenilarvins have the added disadvantage 
of directly impacting the health of the bee. ERIC II pro-
duces four paenilimicins: A1, A2, B1, and B2. In addition, 
paenilarvins A and B are produced as a secondary metab-
olite during the infection of P. larvae [143]. Other non-
ribosomal peptides and peptide-polyketide hybrids are P. 
larvae secondary metabolites which are expected to have 
additional roles in the bacteria’s pathogenicity [149].
Several naturally isolated substances and compounds 
have shown potential in P. larvae inhibition. Both mono-
floral and polyfloral honey demonstrate in  vitro activity 
against P. larvae strains, and this is likely due in part to 
the high concentration of sugar causing extreme osmotic 
stress for the bacteria. In addition, nectar contains several 
antimicrobial secondary plant metabolites whose pres-
ence can be detected in processed honey. Because these 
secondary metabolites are species-specific in their antag-
onism, polyfloral honey tends to confer more resistance 
than monofloral honey, as it contains the metabolites 
from several plant nectars [140]. Propolis, a substance 
derived from plant resins, is used by bees in the con-
struction of their hives and also shows inhibitory activ-
ity against P. larvae [150, 151]. It was also discovered that 
multiple Hypericum extracts have the potential to inhibit 
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P. larvae in vitro, including hyperforin, uliginosin A and 
B, 7-epiclusianone, albasidin AA, and drummondin E 
[144]. Other compounds demonstrating potential to con-
trol P. larvae infections include Azadirachta indica, Vitex 
trifolia, Calendula officinalis, and Nasturtium officinale 
extracts [152, 153], a collection of essential oils [154], and 
frozen as well as freeze-dried sunflower bee pollen [155]. 
Certain other bacterial species demonstrate antagonis-
tic activity to P. larvae, including Bacillus polymachus 
which shows potential as a biocontrol agent [156]. Multi-
ple Enterococcus species have demonstrated antagonistic 
activity to P. larvae, and this is believed to be due to the 
bacteriocin genes found in their genomes [157]. A novel 
P. larvae phage phiIBB-Pl23 produces an endolysin which 
effectively kills P. larvae while at the same time remains 
nontoxic to bees [158].
Different species of honeybees glycosylate their royal 
jelly proteins in distinct patterns, which seems to have 
an influence on their vulnerability to P. larvae infections. 
Apis mellifera lingustica’s royal jelly proteins display 
higher antihypertension activity than those produced by 
Apis cerana cerana and is active at lower levels. Interest-
ingly, this difference in activity grants Apis mellifera lin-
gustica optimized molecular functioning and enhanced 
immune activity, and so the strain is more resistant to P. 
larvae than is Apis cerana cerana in that larval exposure 
to the spores results in infection less frequently [159]. 
Although the strain tested was ERIC I, this may help to 
explain the specificity observed in P. larvae ERIC II infec-
tions. These findings have implications when exploring 
potential techniques to control AFB, as well as in discov-
ering novel techniques for controlling human hyperten-
sive disease.
Another species of bacteria believed to put the honey-
bee at risk is P. apiarius [160]. Although not the primary 
cause of disease, P. alvei acts as a secondary infector in 
cases of European Foulbrood, along with other species 
of pathogenic bacteria including Enterococcus faecalis, 
Brevibacillus laterosporus, Bacillus pumilus, Achromo-
bacter euridice [140], and P. dendritiformis [161].
Snail disease
P. glabratella was originally isolated from visible white 
nodules on snails in a population with high mortal-
ity. This species causes significant mortality in infected 
Biomphalaria glabrata snail populations, and is highly 
contagious among members of the population. Moreover, 
infected snails produce infected eggs causing decreased 
levels of hatching. These findings hold promise for P. 
glabratella as a potential biocontrol agent against the 
tropical parasitic disease Schistosomiasis which com-
monly uses these snails as vectors [162]. This has impli-
cations in developing countries where parasites are a 
significant cause of death. Schistosomiasis ranks second 
globally among parasitic diseases of public health and 
socio-economic importance and is endemic in Africa 
[163].
Opportunistic infections of humans
Several Paenibacillus species have been isolated from 
humans globally (Additional file 1). Although the major-
ity of these colonisations are not harmful to their host, 
some have demonstrated pathogenicity to humans. In 
almost every case, Paenibacillus infections are oppor-
tunistic and tend to infect immunocompromised peo-
ple. Diseases or syndromes associated with Paenibacillus 
infection include chronic kidney disease [164], sickle 
cell disease [165], premature birth [166], Whipple’s dis-
ease [167], hydrocephalus [168], skin cancer, chronic 
interstitial nephropathy, and acute lymphoblastic leuke-
mia [169]. In many of these cases it is unclear whether 
the relationship between the infection and the disease 
was correlated or causal, but it is likely that Paenibacillus 
was simply occupying suitable niches opportunistically. 
Many human-recovered Paenibacillus isolates come 
from elderly patients whose immune systems are gener-
ally weak.
A significant risk factor to Paenibacillus infection 
is the use of intravenous drugs. Intravenous drug use 
grants bacteria and other contaminants entry into the 
blood stream which would normally be unexposed to 
these pathogens. In one case, P. amylolyticus coinfection 
with Lysinibacillus fusiformis caused bacteremia leading 
to sepsis in an immunocompromised patient known to 
use intravenous heroin [170]. Additionally, several cases 
of P. larvae bacteremia have been caused by the use of 
intravenous methadone prepared with honey from hives 
infected with P. larvae. Some pharmacies are known to 
prepare methadone using a viscous substance such as 
honey to prevent patients from misusing it through injec-
tion. If residual P. larvae spores in the honey happen to 
be injected through intentional misuse, they can germi-
nate under proper conditions and cause infection [171].
Paenibacillus isolated from humans have demonstrated 
a variety of strain-dependent drug resistances includ-
ing resistances to norfloxacin, clindamycin, ampicillin, 
and ticarcillinclavulanic acid. Successful drug treatments 
have included cefotaxime, ceftrixone, and a treatment 
involving amikacin and zosyn followed by po Levofloxa-
cin [164, 165, 172].
Dairy spoilage
Another well-known negative aspect of Paenibacillus is 
its role in the spoilage of milk and other dairy products. 
Paenibacillus is among the most important bacterial gen-
era that produce spoilage enzymes in the dairy industry, 
Page 14 of 18Grady et al. Microb Cell Fact  (2016) 15:203 
along with Bacillus and Viridibacillus. Endospores of 
these genera are able to survive extreme conditions 
including high heat, pressure, biocides, and UV irra-
diation, allowing them to withstand pasteurization and 
persist in industrial equipment. Small numbers of Paeni-
bacillus spores can therefore be found in both raw and 
pasteurized milk [173].
Many Paenibacillus strains also grow well at refrig-
eration temperature. Paenibacillus represents more than 
95% of bacteria in raw milk after 10 days of refrigerated 
shelf life [173], while spoilage of pasteurized milk due to 
Paenibacillus is delayed by the germination process of 
spores and usually occurs after 17–21 days [174]. Strains 
that are able to grow at low temperature (6  °C) share 
numerous genetic features including genes that encode 
peptidases with cold-adapted features and cold-adapta-
tion related proteins [175].
While Paenibacillus enzymes can be beneficial to 
other industries (see “Process manufacturing” section), 
their proteases, lipases, and phospholipases negatively 
impact the texture of dairy products, such as curdling 
caused by proteases, as well as the flavour [173]. How-
ever, not all dairy-isolated strains produce these activi-
ties [174]. Paenibacillus species isolated from dairy 
products include P. amylolyticus, P. lactis, P. lentimor-
bus, P. lucanolyticus, P. odorifer, P. peoriae, and P. stel-
lifer [173, 174, 176].
Conclusions
Paenibacillus was separated from Bacillus in 1993, but is 
a paraphyletic genus that is likely to undergo further sub-
division in the future. This diverse genus has relevance 
in many areas, spurring numerous genome sequenc-
ing projects and patents. Many species are well-known 
plant-growth promoters, with various strains capable of 
promoting plant nutrient uptake, controlling phytopath-
ogens, and producing phytohormones. The usefulness of 
inoculating Paenibacillus in the field can be restricted by 
various environmental conditions, but further research 
into the establishment and performance of these spe-
cies within complex soil ecosystems may allow for their 
widespread use as biofertilizer. In addition to agricul-
tural applications, Paenibacillus produces a diversity of 
antimicrobials, enzymes, and exopolysaccharides with 
relevance in medicine, process manufacturing, and biore-
mediation, some of which have already been commercial-
ized. However, the genus is not purely beneficial, with 
some species causing food spoilage, honeybee disease, or 
opportunistic infections in humans. Still, the future can 
expect more discoveries and optimizations that will allow 
Paenibacillus to contribute positively to health and sus-
tainable processes.
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